COMMUNIQUÉS West-GlobeNewswire

MDxHealth (R): MDxHealth Shareholder Transparency Declaration
29/03/2018
Press release - Regulated information - 29 March 2018, 5.45 p.m. CET HERSTAL, BELGIUM and IRVINE, CA - March 29, 2018 - MDxHealth SA (Euronext Brussels: MDXH) ("MDxHealth" or the "Company"), a world leader in molecular [...]
MDxHealth (R) : MDxHealth: Déclaration de Transparence d'un Actionnaire
29/03/2018
C ommuniqué de presse - Information réglementée - 29 mars 2018, 1 7h45 HEC IRVINE, CA, et HERSTAL (BELGIQUE) - le 29 mars 2018 - MDxHealth SA (Euronext Brussels: MDXH) ("MDxHealth" ou la "Société"), un leader mondial [...]
Theratechnologies to Announce Financial Results for First Quarter 2018
29/03/2018
MONTREAL, March 29, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH ) ( Theratechnologies ) announced today that it will issue its financial results for the first quarter ended February 28, 2018, on Thursday, [...]
Theratechnologies annoncera ses résultats du premier trimestre de 2018
29/03/2018
MONTRÉAL, 29 mars 2018 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies ») (TSX: TH ) a annoncé aujourd’hui qu’elle dévoilerait ses résultats financiers jeudi le 5 avril 2018 pour l’exercice financier [...]
Pharma and Biotech Data Science Pioneers to Share What’s Next at Bio-IT World
29/03/2018
BOSTON, March 29, 2018 (GLOBE NEWSWIRE) -- Cambridge Healthtech Institute, a division of Cambridge Innovation Institute, is pleased to once again invite the community to join the knowledge-sharing and celebration of the [...]
Aino Health AB (publ): Aino Health AB signs contract with Finnair
29/03/2018
Aino Health has signed a contract with the Finnish airline Finnair regarding use of Aino's HealthManager platform. Finnair will take Aino Health's HealthManager into use starting from August 2018. "We see that there is [...]
Avinger Announces First-in-Patient use of Extended Nosecone Version of Next Generation Pantheris
29/03/2018
REDWOOD CITY, Calif., March 29, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that Arne Schwindt, M.D., a [...]
Zosano Announces Pricing of Public Offering of Common Stock
29/03/2018
FREMONT, Calif., March 29, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq: ZSAN ), a clinical-stage biopharmaceutical company focused on providing rapid systemic administration of therapeutics to patients [...]
Solid Biosciences Reports Full Year 2017 Financial Results and Provides Corporate Update
29/03/2018
CAMBRIDGE, Mass., March 29, 2018 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (NASDAQ: SLDB ) today reported financial results for the full year ended December 31, 2017 and provided a corporate update. “Since our [...]
Daré Bioscience, Inc. to Announce Full Year 2017 Financial Results and Host a Live Conference Call and Webcast on Monday, April 2, 2018
29/03/2018
SAN DIEGO, March 29, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE ), a clinical-stage, women’s biopharmaceutical company, announced that it has released financial results for the full year ended December [...]
Precision Therapeutics Announces Record STREAMWAY® System Sales in the First Three Months of 2018
29/03/2018
MINNEAPOLIS, March 29, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT ) (“Precision” or “the Company”), today provided a sales update from its Skyline Medical division, producer of the FDA-approved [...]
AIT Granted New Patent for Its Nitric Oxide (NO) Generator and Delivery System
29/03/2018
Patent covers technology for a disposable that filters nitrogen dioxide (NO2) gas and programs the system for use NEW YORK, March 29, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTC:AITB), a clinical-stage medical [...]
Catalyst Pharmaceuticals Announces Submission of New Drug Application for Firdapse® for Treatment of Lambert-Eaton Myasthenic Syndrome
29/03/2018
CORAL GABLES, Fla., March 29, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq: CPRX ), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare [...]
Galectin Therapeutics Reports 2017 Financial Results and Provides Business Update
29/03/2018
NORCROSS, Ga., March 29, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT ), the leading developer of therapeutics that target galectin proteins, today reported financial results for the year ended [...]
Novan Announces Corporate Update Conference Call and Webcast
29/03/2018
MORRISVILLE, N.C., March 29, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (NASDAQ: NOVN ) today announced that the Company will host a conference call on Thursday, April 12, at 8:30 a.m. Eastern Time [...]
NSVRC Kicks Off the 17th Annual Sexual Assault Awareness Month with “Embrace Your Voice” Theme
29/03/2018
Harrisburg, PA, March 29, 2018 (GLOBE NEWSWIRE) -- Building on the powerful voices that have emerged following the #MeToo and Time’s Up movements, the National Sexual Violence Resource Center (NSVRC) is proud to launch [...]
Emblem Signs Key Supplier Agreement with Shoppers Drug Mart
29/03/2018
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, March 29, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (TSXV:EMC.WT) (“Emblem” or the “Company”) , has [...]
Bio-Path Holdings Announces Publication in The Lancet Haematology
29/03/2018
HOUSTON, March 29, 2018 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH ), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of [...]
Spectral Announces Fourth Quarter and Fiscal 2017 Results
29/03/2018
TORONTO, March 29, 2018 (GLOBE NEWSWIRE) -- Spectral Medical Inc., (TSX: EDT ), a Phase III company developing the first treatment for patients with septic shock guided by a companion diagnostic, today announced its [...]

Pages